- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 599
Mayo Clinic enters Elysium in $40m round
The health product developer has now raised more than $71m in debt and equity financing in total having received series C funding from backers including Mayo Clinic Ventures.
Dec 31, 2019Brooks breaks for Syngenta Ventures
Syngenta Ventures has hired Mark Brooks, who worked on the AICPA/CIMA startup accelerator, as it seeks to replenish its team.
Dec 31, 2019Mastercard rendezvous with RiskRecon in acquisition deal
Cyber risk intelligence provider RiskRecon has agreed to an acquisition by Mastercard after raising $40m in capital from investors including Dell Technologies Capital.
Dec 30, 2019Rivian revs up with $1.3bn
Returning investors Ford and Amazon contributed to a round that boosted the electric vehicle developer's funding to more than $2.8bn in 2019 alone.
Dec 27, 2019DraftKings drives itself to public listing
The Fox Sports and Kraft Group-backed fantasy sports contest operator has gone public through a reverse merger, forming a $3.3bn company that will include betting technology producer SBTech.
Dec 27, 2019SkySpecs checks in $17m
Evergy Ventures, Equinor Energy Ventures and existing investors Statkraft Ventures and UL Ventures chipped in as the wind power maintenance platform developer took its total funding to $29m.
Dec 23, 2019F5 finds Shape in $1bn acquisition
Alphabet, Hewlett Packard Enterprise, JetBlue and SingTel are exiting the cybersecurity software producer in a $1bn purchase.
Dec 23, 2019Ripple wraps up $200m series C
SBI returned for a round that increased the valuation of the blockchain-focused money transfer platform to $10bn from a reported $355m three years ago.
Dec 23, 2019Johnson & Johnson takes Taris in acquisition deal
MIT's Taris, which is developing a drug delivery system for bladder diseases, has been purchased by Johnson & Johnson.
Dec 23, 2019Johnson & Johnson takes Taris in acquisition deal
Bristol-Myers Squibb has exited Taris, which is developing a drug delivery system for bladder diseases, in a purchase by Johnson & Johnson.
Dec 23, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


